ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- antibiotic resistance
- avian influenza virus
- food- and waterborne diseases
- healthcare-associated infections
- HIV infection
- influenza in humans, avian origin
- influenza in humans, seasonal
- respiratory diseases
- sexually transmitted infections
- vaccine preventable diseases
- viral hepatitis
Hepatitis C - Annual Epidemiological Report 2016 [2014 data]
In 2014, 35 321 cases of hepatitis C were reported from 28 EU/EEA Member States, a crude rate of 8.8 cases per 100 000 population.
Communicable disease threats report, 26 May - 1 June 2013, week 22